Total Voting Rights

RNS Number : 1222U

Dechra Pharmaceuticals PLC

31 December 2012

 



31 December 2012

Dechra^® Pharmaceuticals PLC

("Dechra" or "the Company") 

In conformity with DTR 5.6.1R, the Company notifies the market of the following:

As at the date of this announcement, the Company's issued share capital consists of 87,069,462 ordinary shares with a nominal value of 1 pence each ("Ordinary Shares"), with voting rights.  The Company does not hold any Ordinary Shares in Treasury.

Therefore, the total number of Ordinary Shares with voting rights is 87,069,462.

The above figure of 87,069,462 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

For further information

Zoe Goulding, Company Secretary            

Telephone number: 01782 771100

About Dechra

Dechra is an international veterinary pharmaceutical business.  Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

TVRVFLBLLLFEFBE